Lensar, Alcon still working on US FTC second request, aim to close before July
MLex summary: Lensar, a medical technology company working on robotic laser treatments for the treatment of cataracts, told the US Securities and Exchange Commission that it's continuing to cooperate with the...To view the full article, register now.
Already a subscriber? Click here to view full article